NeuroPace raises 2025 revenue and gross margin guidance amid record RNS growth and DIXI wind-down
Source: SeekingAlpha
2025-11-04 23:07:14 ET
More on NeuroPace
- NeuroPace, Inc. (NPCE) Q3 2025 Earnings Call Transcript
- NeuroPace, Inc. 2025 Q2 - Results - Earnings Call Presentation
- NeuroPace, Inc. (NPCE) Q2 2025 Earnings Call Transcript
- NeuroPace GAAP EPS of -$0.11 beats by $0.09, revenue of $27.4M beats by $2.77M
- NeuroPace raises 2025 revenue guidance to $94M-$98M as RNS System drives record growth
Read the full article on Seeking Alpha
For further details see:
NeuroPace raises 2025 revenue and gross margin guidance amid record RNS growth and DIXI wind-down
Neuropace Inc.
NASDAQ: NPCE
NPCE Trading
0.62% G/L:
$13.86 Last:
86,351 Volume:
$13.75 Open:
NPCE Latest News
March 03, 2026 04:05:00 pm
NeuroPace Reports Fourth Quarter and Full Year 2025 Financial Results and Reiterates 2026 Outlook
NPCE Stock Data
$508,942,176
26,479,649
0.24%
22
N/A
Medical Equipment & Supplies
Healthcare
US
Mountain View
